Cargando…
Macrolides and viral infections: focus on azithromycin in COVID-19 pathology
The emergence of the new COVID-19 virus is proving to be a challenge in seeking effective therapies. Since the most severe clinical manifestation of COVID-19 appears to be a severe acute respiratory syndrome, azithromycin has been proposed as a potential treatment. Azithromycin is known to have immu...
Autores principales: | Pani, Arianna, Lauriola, Marinella, Romandini, Alessandra, Scaglione, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286256/ https://www.ncbi.nlm.nih.gov/pubmed/32534189 http://dx.doi.org/10.1016/j.ijantimicag.2020.106053 |
Ejemplares similares
-
Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID‐19
por: Lauriola, Marinella, et al.
Publicado: (2020) -
A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy?
por: Vitiello, Antonio, et al.
Publicado: (2021) -
Antibiotic Resistance in Pediatric Infections: Global Emerging Threats, Predicting the Near Future
por: Romandini, Alessandra, et al.
Publicado: (2021) -
Selection of Macrolide and Non-Macrolide Resistance with Mass Azithromycin
Distribution: A Community-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2020) -
Azithromycin in viral infections
por: Oliver, Madeleine E., et al.
Publicado: (2020)